This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
It is a treatment for obesity, overweight, and type 2 diabetes that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors. Mounjaro is also indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. per cent and 2.1
Accretion Pharmaceuticals manufactures medicines for the treatment of a variety of conditions, including cardiovascular, anti-diabetic, anti-fungal, anti-allergic, pain management, vitamins and nutrition, anti-bacterials, anti-ulcerants, and neuropathy management. The company has registered 35.66 crore in the fiscal year 2024.
Factors driving the growth of FDCs One of the primary reasons for the rise of FDCs has been their role in addressing diseases that require multi-drug therapy, such as tuberculosis, cardiovascular conditions, diabetes, and infectious diseases. Rifampicin + Isoniazid + Ethambutol) Antimalarial combinations (e.g.,
2018 ESC/ESH guidelines for the management of arterial hypertension. 2018; 39: 3021–3104. Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2018;71:e127-e248. doi:10.1016/j.jacc.2017.11.006 2017.11.006 Williams B, Mancia G, Spiering W, et al. Eur Heart J.
It was initially approved in 2018 for thrombocytopenia in adults with chronic liver disease scheduled to undergo a procedure. May 21, 2018. Despite efficacious treatments that lead to remission, many patients relapse after multiple lines of therapy. Avatrombopag (oral route). Mayo Clinic. July 1, 2025. Accessed July 25, 2025.
The global asthma report 2018. August 31, 2018. Every inhaler needs to be inspected periodically to make sure that it’s still clean and in good shape. 14,18 Conclusion It may seem like counseling on inhaler use could take too much time, but with practice, it can take minutes. REFERENCES Global Asthma Network. Accessed June 6, 2025.
It consolidates and replaces four previous guideline publications: Garis Panduan Kaunseling Ubat-ubatan, 2019 Garis Panduan Pelaksanaan Kaunseling Ubat-ubatan Secara Maya/Virtual, 2021 Topical Preparations Counselling Guide for Pharmacists, 2018 Garis Panduan Kaunseling Methadone. Notably, all disease-specific discussions have been removed.
December 13, 2018. American Oncology Network. August 8, 2024. Accessed May 15, 2025. How your oncology peers manage the complexities of care. Oncology Live ®. Accessed May 15, 2025. Desimone R. Improve work performance with a focus on employee development. December 12, 2019. Updated January 19, 2024. Accessed May 15, 2025.
Updated June 4, 2018. Accessed July 22, 2025. link] Efficacy and Safety of IBI303 in Adult Patients With Active Ankylosing Spondylitis. ClinicalTrials.gov identifier: NCT02893254. Accessed July 22, 2025.
August 24, 2018. Additionally, like all NSAIDs, meloxicam injection should be used with caution in patients with cardiovascular, gastrointestinal, or renal risk factors. 2 REFERENCES 1. Schwenk E, Mariano E, et al. Designing the ideal perioperative pain management plan starts with multimodal analgesia. Korean Journal of Anesthesiology.
December 2018. link] articles/2018/12/dysmenorrhea-and-endometriosis-in-the-adolescent 4. American Pharmaceutical Association; 2025. Dysmenorrhea and endometriosis in the adolescent. American College of Obstetricians and Gynecologists. Accessed April 28, 2025. Smith RP, Kaunitz AM. UpToDate.
1,2 The authors wrote that a 2018 survey from the Crohn’s and Colitis Foundation reported that health care professionals expressed discomfort when prescribing biosimilars in the pediatric population compared with adults. One patient started Inflectra in 2016 and 2017. There was a slow uptake of infliximab biosimilar use among the ICN centers.
In July 2018, the company completed a transaction with Tasly Pharmaceutical Group for the development, manufacture, and commercialization in China of its allogeneic mesenchymal precursor cell products, Revascor for chronic HF, and MPC-25-IC for acute myocardial infarction.
Thus, the reduced number of newly licensed pharmacists versus PharmD graduates: 2 In 2018, there were 14,905 PharmD graduates and 14,103 taking the NAPLEX for the first time. The number of PharmD graduates will likely dip below 10,000 in the next 5 years (a reduction of 33% from 2018).
Biggest spenders DTC ads are almost exclusively leveraged for brand name drugs, with two-thirds of that spending concentrated on just 39 drugs between 2016 and 2018, according to a Government Accountability Office report. Some of the biggest spenders are shelling out millions to get their brands in front of American audiences.
This has driven a staggering surge in prescriptions, with some reports indicating growth of over 5,000% since 2018 in the United States. Justin Kozak The buzz around GLP-1 agonists like Ozempic and Wegovy is undeniable, fueled by social media virality and impressive clinical results.
On December 13, 2024, Lupin, a global pharmaceutical company, announced the acquisition of anti-diabetes trademarks GIBTULIO, GIBTULIO MET, and AJADUO from Boehringer Ingelheim International GmbH. The move is aimed at strengthening Lupins diabetes portfolio in India. In addition, 25 million people are pre-diabetic.
link] Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act Guidance for Industry, January 2018. Updated May 6, 2020. Accessed June 9, 2025. link] FDA Drug Shortages. Updated December 19, 2024. Accessed June 9, 2025. Subscribe Now!
031), and diagnosis between 2016 and 2018 (OR 1.93, P < 001) as well as 2019 and 2020 (1.88, P < 001). in 2016, representing a period of rapid uptake—and usage was consistently high from 2016 to 2018. 3 The utilization of HER2 therapies increased from 64.6% in 2013 to 80.9%
9 (2018): 1259–1265, [link] [14] LeadingAge and the Strategic Health Information Exchange Collaborative (SHIEC), Health Information Exchange (HIE): A Primer and Provider Selection Guide , accessed June 9, 2025, [link] [15] LeadingAge and SHIEC, HIE: A Primer and Provider Selection Guide. [16] 9 (2018): 1259–1265. 9 (2018): 1259–1265.
Almost all national and international organizations recommend dietary sodium reduction as part of the nonpharmacologic therapy for hypertension. In 2013, the WHO recommends that adults consume <2000 mg/day of sodium. External Links WebMD - What is Iodized Salt?, 2023 WebMD - Himalayan Salt: Is It Good for You?
Patients with dilated cardiomyopathy (DCM) or controls with normal cardiac MRI findings from January 2018 to December 2022 were included. is associated with diffuse myocardial fibrosis, a precursor to heart failure, as shown by increased native T1 z-scores in cardiac MRI. “We µm or smaller aerodynamic diameter (PM2.5)—which
based RWJBarnabas Health, in 2016 as COO and became CEO in 2018. Since rejoining Princeton Health in 2010, Mr. Demetriades has guided the system through major transitions, including its 2018 integration into Philadelphia-based Penn Medicine. a role she held since 2018. CEO of Community Medical Center (Toms River, N.J.).
billion takeover bid for Verve Therapeutics, upgrading a collaboration between the two companies that dates back to 2023. billion takeover bid for Verve Therapeutics, upgrading a collaboration between the two companies that dates back to 2023.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content